Clients
Novacyt S.A.
Novacyt is an international diagnostics business delivering a broad portfolio of in vitro and molecular diagnostic tests for a wide range of infectious diseases, enabling faster, more accurate, accessible testing to improve healthcare outcomes. The Company provides customers with a seamless sample-to-result workflow using its integrated and scalable instrumentation/solutions. The Company specialises in the design, manufacture, and supply of real-time PCR kits, reagents and a full range of laboratory and qPCR instrumentation for molecular biology research and clinical use. Novacyt offers one of the world's most varied and comprehensive range of qPCR assays, covering human, veterinary, biodefence, environmental, agriculture and food testing.
The Company will report its unaudited financial results for the six months ended 30 June 2024 on Thursday, 26 September 2024.
Investors can sign up to Investor Meet Company and add to meet Novacyt S.A. here: https://www.investormeetcompany.com/novacyt-sa/register-investorThursday 26 September 2024 at 11am BST
| Event | Date |
| Year End | December |
| Half Year End | June |
| Preliminary Results* | May |
| Interim Results* | September |
| AGM* | August |
* Months based on previous announcements of this kind
.png "NCYT - Interims deck (September 2024)")
NCYT - Interims deck (September 2024)
Who We Work With
Novacyt S.A.
Novacyt is an international diagnostics business delivering a broad portfolio of in vitro and molecular diagnostic tests for a wide range of infectious diseases, enabling faster, more accurate, accessible testing to improve healthcare outcomes. The Company provides customers with a seamless sample-to-result workflow using its integrated and scalable instrumentation/solutions. The Company specialises in the design, manufacture, and supply of real-time PCR kits, reagents and a full range of laboratory and qPCR instrumentation for molecular biology research and clinical use. Novacyt offers one of the world's most varied and comprehensive range of qPCR assays, covering human, veterinary, biodefence, environmental, agriculture and food testing.
The Company will report its unaudited financial results for the six months ended 30 June 2024 on Thursday, 26 September 2024.
Investors can sign up to Investor Meet Company and add to meet Novacyt S.A. here: https://www.investormeetcompany.com/novacyt-sa/register-investorThursday 26 September 2024 at 11am BST
| Event | Date |
| Year End | December |
| Half Year End | June |
| Preliminary Results* | May |
| Interim Results* | September |
| AGM* | August |
* Months based on previous announcements of this kind
NCYT - Interims deck (September 2024)
Leave a comment